Publication | Open Access

Lipophilic 1-?-d-arabinofuranosyl cytosine derivatives in liposomal formulations for oral and parenteral antileukemic therapy in the murine L1210 leukemia model

Hematological MalignancyLipid PreparationMedicinal ChemistryMedicineMixed-phenotype Acute LeukemiaMalignant Blood DisorderLiposomal FormulationsPharmacotherapyAnti-cancer AgentPharmacologyRadiation OncologyLipophilic 1-Drug DiscoveryCytosine Derivatives